Nathan Peiffer-Smadja

18PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular medicineBioinformatic methods developmentEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jun 25, 2026
Comparing risk factors in severe COVID-19 using machine learning and non-machine learning methods: analysis from 2 international randomized controlled trials.

|Apr 29, 2026
High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons.

|Feb 16, 2026
How Can Pharmacology Help Us Overcome the Challenges of Drug Repositioning as Antivirals to Treat Emerging Pathogens? The Example of Covid-19.

Inès Ben Ghezala, Nathan Peiffer-Smadja, Caroline Solas

|Oct 07, 2024
Implementation of a Clinical Decision Support System for Antimicrobial Prescribing in Sub-Saharan Africa: Multisectoral Qualitative Study.

Nathan Peiffer-Smadja, Sophie Descousse, Elsa Courrèges

|Sep 05, 2024
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.

Maxime Beaulieu, Alexandre Gaymard, Clément Massonnaud

|Mar 29, 2024
Cardiac Adverse Events and Remdesivir in Hospitalized Patients With COVID-19: A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.

Vida Terzić, Joe Miantezila Basilua, Nicolas Billard

Pageof 3

Frequent Collaborators

3 joint publications

Jérémie Guedj

3 joint publications

Guillaume Lingas

2 joint publications

Armel Poda

2 joint publications

Abdoul-Salam Ouedraogo